3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
14
fludarabine
8
Rituximab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Vincristine
4
Doxorubicin
4
Dexamethasone
4
zanubrutinib
3
Prednisone
3
Nivolumab
3
Etoposide
3
tazemetostat
2
tafasitamab
2
pirtobrutinib
2
pembrolizumab
2
glofitamab
2
etoposide phosphate
2
cemiplimab
2
acalabrutinib
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Cisplatin
2
Cell- and Tissue-Based Therapy
2
Biopsy
2
venetoclax
1
varlilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.